Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT07648823Early Phase 1Recruiting
Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma
Glioblastoma (GBM)Recurrent GlioblastomaRecurrent Glioblastoma (WHO-Grade IV Glioma)+1 more
Principalinvestigator
NCT07655869Early Phase 1Recruiting
[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
Recurrent Glioblastoma IDH WildtypeRecurrent High-Grade Gliomas
Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zhaohui Zhu, M.D.

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Moderately Similar
1 trials

Shared therapeutic areas:

Glioblastoma (GBM)Recurrent GlioblastomaRecurrent Glioblastoma IDH Wildtype+1 more

Worked with same sponsors:

Beijing Tiantan Hospital
Collaborated on 1 trial
Similarity Score44%

Zhaohui Zhu

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Related
1 trials

Shared therapeutic areas:

Recurrent Glioblastoma IDH WildtypeRecurrent High-Grade Gliomas

Worked with same sponsors:

Beijing Tiantan Hospital
Collaborated on 1 trial
Similarity Score24%

Nicholas Butowski, MD

University of California, San Francisco

Related
5 trials

Shared therapeutic areas:

Recurrent GlioblastomaRecurrent High-Grade Gliomas
Similarity Score12%

Ugur T. Sener, MD

Mayo Clinic in Rochester

Related
3 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Tracy Batchelor, MD, MPH

Massachusetts General Hospital

Related
5 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Benjamin M Ellingson

UCLA / Jonsson Comprehensive Cancer Center

Related
3 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Lisa Franklin

Istari Oncology

Related
3 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Jane Robertson

AstraZeneca

Related
10 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Jiayi Chen, MD

Ruijin Hospital

Related
3 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Recurrent Glioblastoma
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT07648823Early Phase 1PrincipalInvestigator

Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma

Glioblastoma (GBM)Recurrent GlioblastomaRecurrent Glioblastoma (WHO-Grade IV Glioma)+1 more
Recruiting
NCT07655869Early Phase 1PrincipalInvestigator

[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma

Recurrent Glioblastoma IDH WildtypeRecurrent High-Grade Gliomas
Recruiting

All 2 trials loaded